London-based Meridian Health Ventures has raised a €44.7 million transatlantic fund in partnership with National Health Service trusts. The recent fund aims to support UK healthtech and medtech startups.
- Meridian Health Ventures, formerly KHP Ventures, was launched in 2021 under the leadership of Nadine Hachach-Haram. It was established through a partnership between General Catalyst, Speedinvest, and several NHS trusts, including Guy’s and St Thomas’, King’s College Hospital, and University College London, alongside US hospital groups Cedars-Sinai Medical Center and Hartford HealthCare.
- Meridian Health Ventures is the first NHS-backed and transatlantic VC fund, supporting healthcare startups and helping them scale. Its portfolio includes Doccla, deepc, Patchwork, Tympa Health, Apian, iFAST Diagnostics, PocDoc, Phare Health, 52 North, and MediShout.
- In October 2024, Meridian Health Ventures launched Europe’s first mental healthtech fund, the IMH Fund, together with the Wellcome Trust and South London and Maudsley NHS Trust. The fund supports solutions for depression, anxiety, psychosis, early diagnosis, prevention, and access to care.
- The fresh fund plans to support healthtech and medtech startups by helping them expand their operations, enhance product development, and scale both in the UK and the US. Moreover, the fund also aims to facilitate integration into healthcare systems, assist with regulatory processes, and help startups grow their teams to meet demand.
"With this fund, we want to supercharge the growth of the most promising innovations so they can deliver direct benefits to the NHS’s patients and workforce," claims Dr Nadine Hachach-Haram, co-Managing Partner at Meridian Health Ventures.
